These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 1826874)
1. [Bacterial infections. Progress and new prospects in chemo-antibiotic therapy]. Olivieri A; Fostini R; Xerri L; Recchia G Clin Ter; 1991 Jan; 136(1):53-61. PubMed ID: 1826874 [TBL] [Abstract][Full Text] [Related]
2. Fluoroquinolones: how to use (but not overuse) these antibiotics. Sable CA; Scheld WM Geriatrics; 1993 Jun; 48(6):41-4, 49-51. PubMed ID: 8500773 [TBL] [Abstract][Full Text] [Related]
3. Resistance situation of oral antibiotics in the Scandinavian countries with special reference to the fluoro-quinolones. Midtvedt T Scand J Infect Dis Suppl; 1990; 68():7-13. PubMed ID: 2218426 [TBL] [Abstract][Full Text] [Related]
4. The role of the fluoroquinolones in primary care practice. Harding GK Clin Invest Med; 1989 Feb; 12(1):71-3. PubMed ID: 2920484 [No Abstract] [Full Text] [Related]
5. Prescribing considerations in fluoroquinolone therapy. Gentry LO Pharmacotherapy; 1993; 13(2 Pt 2):39S-44S. PubMed ID: 8474937 [TBL] [Abstract][Full Text] [Related]
6. Quinolones for short-term treatment of uncomplicated urinary tract infection. Kadiri S; Ajayi SO; Toki RA East Afr Med J; 1999 Oct; 76(10):587-9. PubMed ID: 10734512 [TBL] [Abstract][Full Text] [Related]
8. Rufloxacin (MF-934): in vitro and in vivo antibacterial activity. Ravizzola G; Pinsi G; Pirali F; Colombrita D; Foresti I; Peroni L; Turano A Drugs Exp Clin Res; 1989; 15(1):11-5. PubMed ID: 2743869 [TBL] [Abstract][Full Text] [Related]
9. Therapy of urinary tract infections in the elderly: role of fluoroquinolones. Sant GR; Wainstein M Urology; 1990 Jan; 35(1 Suppl):19-21. PubMed ID: 2404371 [No Abstract] [Full Text] [Related]
10. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
11. [Tested and new chemotherapy in infectious diseases]. Hoigné R; Keller MF Schweiz Med Wochenschr; 1972 Jul; 102(27):933-40. PubMed ID: 4558901 [No Abstract] [Full Text] [Related]
14. New agents in development for the treatment of bacterial infections. Abbanat D; Morrow B; Bush K Curr Opin Pharmacol; 2008 Oct; 8(5):582-92. PubMed ID: 18761107 [TBL] [Abstract][Full Text] [Related]
15. [Clinical trial of a new broad-spectrum cephalosporin: HR 756 (cefotaxime)]. Poletti T; Bertola D; Pellerito R; Soragna A Minerva Med; 1980 Jul; 71(27):1935-43. PubMed ID: 6248823 [TBL] [Abstract][Full Text] [Related]
16. [Trial of use of a new oral antibiotic: cephalexin in granules in 59 children]. Bovier-Lapierre M; David M; Lauras B Lyon Med; 1971 Dec; 226(20):895-900. PubMed ID: 5144397 [No Abstract] [Full Text] [Related]
17. [Antibiotic therapy by first intention]. Bastin R Rev Prat; 1983 Oct; 33(45):2361-76. PubMed ID: 6648276 [No Abstract] [Full Text] [Related]
18. [Review of oral cephalosporins. Basis for a rational choice]. Forti IN Medicina (B Aires); 1994; 54(5 Pt 1):439-58. PubMed ID: 7658980 [TBL] [Abstract][Full Text] [Related]
19. [Quinolones]. Lode H Schweiz Med Wochenschr; 1988 Dec; 118(49):1823-30. PubMed ID: 3064290 [TBL] [Abstract][Full Text] [Related]
20. [Antibacterial and anti-algal activity if two traditional drugs in the treatment of urinary tract infection and cystitis in Mali]. Rokia S; Drissa D; Seydou D; Colette E; Flabou B Mali Med; 2006; 21(1):18-24. PubMed ID: 17390524 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]